Influences of anti-reflection surface treatment on legibility of reflective-type displays

[[abstract]]Influences of anti-reflection surface treatment, radius of curvature and ambient illuminance on legibility of reflective-type displays were studied. The results showed that legibility mainly depended on the surface treatment. Better surface treatment also produced less visual fatigue after the letter-search task.[[fileno]]2020418010068[[department]]工工

Polyhedral Oligomeric Silsesquioxane Films for Liquid Crystal Alignment

Polyhedral oligomeric silsesquioxanes (POSSs) with nano-size cage structures have been conventionally incorporated into polymers to improve the polymers’ physical properties. In this work, POSS films formed by using POSS nanomaterials with different thermal treatments have been implemented as liquid crystal (LC) alignment films instead of using conventional polyimide alignment films adopted in the LC displays industry. The homeotropic alignment of LCs anchored on POSS films was observed. The morphology and surface energy of POSS films were measured to study their effects on LC orientation anchored on the POSS films

Growth of ZnO Nanorods and Their Applications for Liquid Crystal Devices

Different morphologies of ZnO nanorods were synthesized by using the two-step hydrothermal method, and they were applied to liquid crystal (LC) alignment films. The morphology of the ZnO nanorods, including length, diameter, and density, were controlled by the growth time, which ranged from 16 to 26 min. The morphology and the chemical features both contributed to the surface wettability of the ZnO nanorods. The LC pretilt angle on the ZnO nanorods was successfully controlled from homeotropic (∼89.0°) to homogeneous (∼1.7°) alignments, as the contact angle of water on ZnO nanorods was changed from 93 to 28° with the growth time. The analysis of X-ray diffraction and X-ray photoelectron spectroscopy showed that the crystallite size of ZnO nanorods increased with the growth time, while the oxygen vacancy decreased. The ZnO nanorods grown on the ITO glass substrate also improve the transmission of LCDs due to the antireflection effect

Polysomnography and Nocturia Evaluations after Uvulopalatopharyngoplasty for Obstructive Sleep Apnea Syndrome

A higher incidence rate of nocturia in patients with obstructive sleep apnea (OSA) has been observed. We investigated the differences in clinical examinations between OSA patients with and without nocturia, and further compared those with successful and unsuccessful uvulopalatopharyngoplasty (UPPP). This retrospective study enrolled 103 patients with OSA undergoing UPPP. Patients were diagnosed with OSA by following the 2018 American Academy of Sleep Medicine (AASM) Scoring Manual Version 2.5. Patients were divided into two groups depending on if they urinated more than twice per night. The medical data of body mass index (BMI), nocturia frequency per night, apnea–hypopnea index (AHI), Epworth Sleepiness Scale (ESS), International Prostatic Symptom Score (IPSS), and Overactive Bladder Symptom Score (OABSS) were analyzed before and after uvulopalatopharyngoplasty (UPPP) surgery. All of the measurements were compared between successful and unsuccessful surgery in the non-nocturia or nocturia groups, respectively. Fifty patients (41 males and nine females) without nocturia were assigned to group 1, and 53 patients (43 males and 10 females) with nocturia were assigned to group 2. Nocturia frequency and post-surgery AHI in group 2 were significantly higher than those in group 1 (p < 0.05). Significant decreases in IPSS and OABSS were observed in the successful surgery subgroup of group 2 (p < 0.05). A significant decrease in post-surgery AHI was observed between unsuccessful and successful surgery in patients with nocturia (p < 0.05), but not in the non-nocturia group (p > 0.05). Although AHI had a significant correlation to nocturia frequency in all OSA patients before UPPP, no significant correlation between AHI reduction and nocturia frequency was found. UPPP appeared to be an effective treatment for nocturia associated with OSA. OSA should be taken into consideration for patients who complain of nocturia syndrome. The relationship of AHI reduction and nocturia improvement after OSA treatment with UPPP is still unclear. In addition, it is necessary to establish the existence of nocturia in patients with OSA, as a result of its high prevalence in OSA patients. UPPP could reduce the symptoms of OSA and could also contribute to a reduction of nocturia even in the unsuccessful surgery group